# APOMORPHINE HYDROCHLORIDE
> **ANDA212025** · Abbreviated New Drug Application (Generic) · Sponsor: TP ANDA HOLDINGS · Approved 2022-02-23
## Drug
- **FDA Application Number:** ANDA212025
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** APOMORPHINE HYDROCHLORIDE
- **Generic name:** APOMORPHINE HYDROCHLORIDE
- **Active ingredients:** APOMORPHINE HYDROCHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** TP ANDA HOLDINGS
- **Manufacturer:** TruPharma, LLC
- **First approval:** 2022-02-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212025)
---
*AI Analytics · CC0 1.0*